Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in BRIDGEBIO PHARMA INC
BNP PARIBAS FINANCIAL MARKETS holds 1.6M shares of BBIO (BRIDGEBIO PHARMA INC), worth $121.8M as of 2025-Q4. The position was increased (++149.1% shares). BBIO represents 0.1% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$121.8M
Current Shares
1.6M
Total Value Change
+$121.5M
Total Shares Change
+1.6M
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.6M |
+149.1% |
| $121.8M |
| 0.1% |
| $75.48 |
49 |
| 2025-Q3 | Increased | 639,264 | +45.6% | $33.2M | 0.0% | $51.96 | 39 |
| 2025-Q2 | Increased | 439,066 | +39.5% | $19M | 0.0% | $44.86 | 38 |
| 2025-Q1 | Increased | 314,702 | +1148.3% | $10.9M | 0.0% | $35.11 | 45 |
| 2024-Q4 | Decreased | 25,210 | -33.7% | $691,762 | 0.0% | $27.32 | 0 |
| 2024-Q3 | Increased | 38,039 | +186.0% | $968,473 | 0.0% | $24.94 | 40 |
| 2024-Q2 | Decreased | 13,301 | -90.4% | $336,914 | 0.0% | $25.33 | 0 |